	CRF Health, a global provider of eCOA solutions for the life sciences industry, announced its TrialMax

eCOA solution supports diabetes clinical trials. Developed with clinicians and patients to optimize usability and compliance, the solution enables investigators to collect patient reported outcome assessments and deliver defensible data, while minimizing patient and site burden. The solution is already being used in four major global diabetes trials, covering 700 investigative sites and 3,250 patients. The TrialMax Touch® eDiary integrates with the Entra Health MyGlucoHealth

 wireless glucometer, enabling automatic transfer of measurements to a patient's eDiary. 

News

CRF Health, the leading global provider of eCOA solutions for the life sciences industry, today announced a complete TrialMax® eCOA solution for diabetes clinical trials.